Keywords: genentech, details, its, horizon, long-term, strategy, financial
Genentech details its "Horizon 2010" long-term strategy and financial goals
Article | 22 March 2004
California, USA-based Genentech has disclosed its financial expectations for 2004 and outlined details of its long-range strategy, termed Horizon 2010, at its ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- AstraZeneca's naloxegol meets endpoints; EMA validates Gilead's sofosbuvir MAA
- Is failure to adopt business process management putting the pharma industry at risk?
- Boehringer Ingelheim gets FDA warning letter on cGMP failures
- Sanofi and Regeneron's dupilumab shows 87% reduction in risk of asthma exacerbations
- Ignyta acquires Actagene Oncology and entry into cancer personalized medicine
